ARK Genomic Revolution ETF (ARKG) Holdings $24.90 +1.29 (+5.46%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$24.91 +0.01 (+0.04%) As of 07/18/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock Top 34 ARKG HoldingsRankCompanyCurrent PriceWeightShares Held1TEMTempus AI$60.98+0.5%10.10%1,613,9422CRSPCRISPR Therapeutics$65.13+18.2%9.48%2,183,9543TWSTTwist Bioscience$35.17-1.9%7.47%2,218,1604GHGuardant Health$46.46-1.7%6.48%1,400,6545NTRANatera$138.90-3.1%5.67%349,2956RXRXRecursion Pharmaceuticals$5.84+5.8%5.59%12,144,7207PSNLPersonalis$6.19-4.5%4.37%7,383,3168ADPTAdaptive Biotechnologies$10.39-1.0%4.21%4,185,6099SDGRSchrodinger$21.45-0.9%3.95%2,035,38510CDNACareDx$11.91+0.8%3.93%2,176,442 Get the Latest News and Ratings for ARKG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11TXG10x Genomics$12.15-2.4%3.54%3,439,49912IONSIonis Pharmaceuticals$41.76-1.0%3.35%933,60413BEAMBeam Therapeutics$20.75+1.5%3.25%2,040,71814VCYTVeracyte$23.51-2.9%3.15%1,235,94915NTLAIntellia Therapeutics$12.06+1.9%2.69%3,055,87216ABSIAbsci$3.12+8.3%2.65%10,059,77517ILMNIllumina$96.14-1.8%2.45%283,55318ARCTArcturus Therapeutics$13.50-0.3%2.12%1,779,33319NRIXNurix Therapeutics$11.21-7.3%1.86%1,630,01720MASS908 Devices$6.70-1.2%1.74%2,747,23321AMGNAmgen$294.76-1.2%1.56%60,02022VEEVVeeva Systems$282.03+2.0%1.38%51,63623PACBPacific Biosciences of California$1.37-1.4%1.32%11,669,67424BFLYButterfly Network$1.87+1.1%1.30%6,653,48425QSIQuantum-Si$1.76-3.3%1.30%8,257,99826VRTXVertex Pharmaceuticals$459.81-0.7%1.05%24,91627INCYIncyte$67.86-1.6%1.02%159,12328CERSCerus$1.36-0.7%0.92%7,215,21429REGNRegeneron Pharmaceuticals$542.52-1.4%0.63%12,98830PRMEPrime Medicine$4.13+5.9%0.50%2,407,75531CMPSCOMPASS Pathways$4.30+10.8%0.38%1,710,54332LABStandard BioTools$1.23-1.6%0.38%3,272,29333CAICAI International$30.19-3.5%0.12%48,70234GOLDMAN FS TRSY OBLIG INST 468N/A0.10%1,023,528 Geographic ExposureUnited States88.4%Switzerland11.0%Netherlands0.3%Currency ExposureUSD99.6%Sector ExposureHealth Care86.7%Consumer Discretionary5.8%Information Technology5.5%Technology1.2%Industry ExposureBiotechnology48.0%Life Sciences Tools & Services22.6%Health Care Equipment & Supplies11.5%Diversified Consumer Services5.8%Health Care Providers & Services4.6%IT Services4.0%Electronic Equipment, Instruments & Components1.5%Software1.2%SubIndustry ExposureBiotechnology48.0%Life Sciences Tools & Services29.8%Health Care Services4.6%Health Care Equipment4.4%Internet Services & Infrastructure4.0%Electronic Equipment & Instruments1.5%Application Software1.2% Related Companies and Tools Related Companies ROBO Global Robotics & Automation ETF Portfolio iShares MSCI ACWI Low Carbon Target ETF Portfolio VictoryShares Core Plus Intermediate Bond ETF Portfolio SPDR S&P 500 ESG ETF Portfolio Amplify Transformational Data Sharing ETF Portfolio iShares Future AI & Tech ETF Portfolio Global X Cybersecurity ETF Portfolio Global X S&P 500 Catholic Values ETF Portfolio ARK Autonomous Technology & Robotics ETF Portfolio iShares ESG MSCI USA Leaders ETF Portfolio This page (BATS:ARKG) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
